SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001181431-07-069094.pdf 0001181431-07-069094.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001181431-07-069093.pdf 0001181431-07-069093.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001181431-07-069097.pdf 0001181431-07-069097.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001181431-07-069098.pdf 0001181431-07-069098.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001181431-07-069100.pdf 0001181431-07-069100.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-07-063917.pdf 0001209191-07-063917.rtf 0001209191-07-063917.xls
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-07-063928.pdf 0001209191-07-063928.rtf 0001209191-07-063928.xls
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-07-063962.pdf 0001209191-07-063962.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-07-063963.pdf 0001209191-07-063963.rtf
Nov 14, 2007	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-07-063964.pdf 0001209191-07-063964.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE